Stock listing

AB3A Stock Price, News, Filings & Events — Sarepta Therapeutics, Inc.

Selected listing: AB3A · GETTEX · EUR · DE

AB3A:GETTEX is the listing for Sarepta Therapeutics, Inc., a company dedicated to developing innovative therapies for rare genetic disorders. With a market capitalization of around €1.82 billion, Sarepta is focused on addressing serious unmet medical needs through its research and development efforts. The company continues to advance its pipeline of treatments, contributing to the evolving landscape of rare disease therapies. Recent news and filings reflect its ongoing commitment to bringing new solutions to patients.

AB3A:GETTEXEURDEUpdated July 24, 2026
Sarepta Therapeutics, Inc. logo
Ticker
AB3A:GETTEX
Asset type
Stock
Market cap
$1.66B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
GETTEX
Currency
EUR

Sarepta Therapeutics, Inc. AB3A:GETTEX stock context

AB3A:GETTEX is the listing for Sarepta Therapeutics, Inc., a company dedicated to developing innovative therapies for rare genetic disorders. With a market capitalization of around €1.82 billion, Sarepta is focused on addressing serious unmet medical needs through its research and development efforts. The company continues to advance its pipeline of treatments, contributing to the evolving landscape of rare disease therapies. Recent news and filings reflect its ongoing commitment to bringing new solutions to patients.

Research Sarepta Therapeutics, Inc.

Alternate listings